ETN
64
4
HUM
25
4
FSLR
50
6
MSI
52
3
IBM
53
2
MCD
52
3
HIG
48
5
HSY
32
3
EBAY
42
2
SO
48
6
NOV
45
2
SNA
56
3
CAH
44
7
SCHW
40
3
SLG
37
6
GM
55
6
KSS
36
2
BAX
38
2
CF
47
5
CVS
27
2
ETN
64
4
HUM
25
4
FSLR
50
6
MSI
52
3
IBM
53
2
MCD
52
3
HIG
48
5
HSY
32
3
EBAY
42
2
SO
48
6
NOV
45
2
SNA
56
3
CAH
44
7
SCHW
40
3
SLG
37
6
GM
55
6
KSS
36
2
BAX
38
2
CF
47
5
CVS
27
2
Financhill
Back

Marker Therapeutics 10K Form

Buy
53

MRKR
Marker Therapeutics

Last Price:
$3.79
Seasonality Move:
35.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MRKR News And Ratings

See the #1 stock for the next 7 days that we like better than MRKR

MRKR Financial Statistics

Sales & Book Value

Annual Sales: $5.5M
Cash Flow: $1.2M
Price / Cash Flow: 0
Annual Sales: $0.83
Price / Book: 4.55

Profitability

EPS (TTM): -1.10000
Net Income (TTM): $-9.7M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Marker Therapeutics Earnings Forecast

Key Marker Therapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for MRKR have been equal to 206.11% of Gross Profit Margin.
  • The Interest Expense is -0.03% of Operating Income.
  • Per Share Earnings over the last 17 years have been positive in 11 years.

Marker Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MRKR
CUSIP: 57055L
Website: http//www.markertherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MRKR Technical Analysis vs Fundamental Analysis

Buy
53
Marker Therapeutics (MRKR) is a Buy

Is Marker Therapeutics a Buy or a Sell?